Flecainide-Associated Cardiogenic Shock in a Patient with Atrial Fibrillation

Flecainide is a frequently used antiarrhythmic drug, recommended by current guidelines as a first-line treatment option for restoring and maintaining sinus rhythm in patients with atrial fibrillation and no significant structural heart disease. In overdose, it can induce severe cardiogenic shock. Ca...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Case Rep Cardiol
Hlavní autoři: Gjermeni, Erind, Bollmann, Andreas, Hindricks, Gerhard, Müssigbrodt, Andreas
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi 2019
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6885768/
https://ncbi.nlm.nih.gov/pubmed/31827935
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/4820652
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky